![](/img/cover-not-exists.png)
The Medication Level Variability Index (MLVI) as a potential predictive biomarker of graft‐versus‐host disease in pediatric hematopoietic stem cell transplant patients
Skeens, Micah A., Dietrich, Mary S., Ryan‐Wenger, Nancy, Gilmer, Mary Jo, Mulvaney, Shelagh A., Akard, Terrah FosterJournal:
Pediatric Transplantation
DOI:
10.1111/petr.13451
Date:
May, 2019
File:
PDF, 353 KB
2019